SEC Form 4 · accession 0001127602-17-009216
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 28, 2017
Accepted (ET)
Mar 1, 2017 · 3:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2017 | S | 100 | $88.37 | D | 382,900 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.375 | D | 382,800 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $88.38 | D | 382,600 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.40 | D | 382,500 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $88.44 | D | 382,300 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $88.45 | D | 382,100 | D | |
| Common Stock | Feb 28, 2017 | S | 100 | $88.62 | D | 382,000 | D | |
| Common Stock | Feb 28, 2017 | S | 200 | $88.64 | D | 381,800 | D | |
| Common Stock | Feb 28, 2017 | S | 50 | $88.785 | D | 381,750 | D | |
| Common Stock | Feb 28, 2017 | S | 20 | $88.885 | D | 381,730 | D | |
| Common Stock | Feb 28, 2017 | F | 2,396 | $89.54 | D | 379,334 | D | |
| Common Stock | Feb 28, 2017 | G | 13,656 | $0.00 | D | 365,678 | D | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.